Bayshore Pharmaceuticals, LLC – Metformin Hydrochloride Extended-Release Tablets USP, 500 mg & 750 mg

← Back to Drug Recalls

Recall Category: Drug Recalls

Date: 08/20/2020

Brand: Bayshore Pharmaceuticals, LLC

Product: Metformin Hydrochloride Extended-Release Tablets USP, 500 mg & 750 mg

Recall Reason: Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity

Company: Bayshore Pharmaceuticals, LLC

Dosage Form: Tablet

Recall Issue Type: Other Recall Issue

View FDA Drug Recall Notice